Hari Krishna Ananthula, Scott Parker, Erin Touchette, R. Mark Buller, Gopi Patel, Daniel Kalman, . . . Pankaj B. Desai. (2018). Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents. BMC.
Chicago Style (17th ed.) CitationHari Krishna Ananthula, et al. Preclinical Pharmacokinetic Evaluation to Facilitate Repurposing of Tyrosine Kinase Inhibitors Nilotinib and Imatinib as Antiviral Agents. BMC, 2018.
MLA (9th ed.) CitationHari Krishna Ananthula, et al. Preclinical Pharmacokinetic Evaluation to Facilitate Repurposing of Tyrosine Kinase Inhibitors Nilotinib and Imatinib as Antiviral Agents. BMC, 2018.
Warning: These citations may not always be 100% accurate.